From a market point of view, short term investors expected good news and therefore a price rise. The massive market players will most certainly understand the implications of the announcement to the extent you have and that is probably the reason for the dumping.
Do you hold zero optimism for this share?
- Forums
- ASX - By Stock
- interim data from can-003 clinical trial
IMM
immutep limited
Add to My Watchlist
2.00%
!
24.5¢

From a market point of view, short term investors expected good...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $357.7M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 24.0¢ | $419.2K | 1.737M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 301706 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 28117 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 301706 | 0.240 |
6 | 305882 | 0.235 |
11 | 330086 | 0.230 |
13 | 511200 | 0.225 |
17 | 1170248 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 28117 | 2 |
0.250 | 161392 | 6 |
0.255 | 114804 | 6 |
0.260 | 268899 | 9 |
0.265 | 486184 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online